{"id":1203,"date":"2016-03-22T16:49:09","date_gmt":"2016-03-22T20:49:09","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=1203"},"modified":"2016-03-22T17:20:35","modified_gmt":"2016-03-22T21:20:35","slug":"secondaries-announced-3-22-2016","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-3-22-2016\/","title":{"rendered":"Secondaries announced 3.22.2016"},"content":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. <\/p>\n<p>Company: \tCelator Pharmaceuticals<br \/>\nSymbol: \tCPXX<br \/>\nPrice: \t\tLast trade $10.01<br \/>\nTrade Date: \t3\/23<br \/>\nShares: \t3 million<br \/>\nUnderwriter(s) Stifel, Needham &#038; Co.<br \/>\nCo Manager(s)\tRoth Capital Partners, H.C. Wainwright, National Securities<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: \tSun Communities, Inc.<br \/>\nSymbol: \tSUI<br \/>\nPrice: \t\tLast trade $68.36<br \/>\nTrade Date: \t3\/24<br \/>\nShares: \t4 million<br \/>\nUnderwriter(s) \tBofA Merrill Lynch, Citigroup<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: \tShell Midstream Partners, L.P.<br \/>\nSymbol: \tSHLX<br \/>\nPrice: \t\tLast trade $34.03<br \/>\nTrade Date: \t3\/23<br \/>\nShares: \t8.5 million<br \/>\nUnderwriter(s) \tBarclays<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company:           The Michaels Companies, Inc.-BLOCK<br \/>\nSymbol:            MIK<br \/>\nPrice:             Last trade $26.93<br \/>\nTrade Date:        3\/23<br \/>\nShares:            17 million<br \/>\nUnderwriter(s) J.P. Morgan, BofA Merrill Lynch<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. Company: Celator Pharmaceuticals Symbol: CPXX Price: Last trade $10.01 Trade Date: 3\/23 Shares: 3 million Underwriter(s) Stifel, Needham &#038; Co. Co Manager(s)[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[773,38,692,678],"class_list":["post-1203","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-cpxx","tag-mik","tag-shlx","tag-sui"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1203","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=1203"}],"version-history":[{"count":2,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1203\/revisions"}],"predecessor-version":[{"id":1205,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1203\/revisions\/1205"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=1203"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=1203"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=1203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}